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Specific isoforms of laminin (LN) are concentrated at neuro-
muscular junctions (NMJs) where they may participate in syn-
aptic organization or function. In myotubes from C2 cells, LN is
concentrated within the majority of spontaneous acetylcholine
receptor (AChR) aggregates. Neural agrin substantially in-
creases this colocalization, suggesting that agrin can recruit LN
into AChR aggregates. Addition of LN to C2 myotubes induces
a more than twofold increase in the number of AChR aggre-
gates. These aggregates have a larger size and are more dense
than are those induced by agrin, suggesting that LN is involved
in the growth and/or stabilization of AChR aggregates. Consis-
tent with this hypothesis, an antiserum to LN reduces the size
of individual AChR aggregates but increases their number. In
C2 myotubes, extracellular matrix receptors containing the in-
tegrin b1 subunit are poorly colocalized with AChR aggregates,
suggesting that integrins may not be involved in LN-induced
aggregation. In contrast, almost all AChR aggregates are asso-
ciated with dystroglycan immunoreactivity, and monoclonal an-
tibody (mAb) IIH6 against a-dystroglycan (a-DG), a LN and
agrin receptor, causes a concentration-dependent inhibition of
LN-induced aggregation. Moreover, S27 cells, which lack a
functional a-DG, and two C2-derived cell lines expressing an-
tisense DG mRNA fail to aggregate AChRs in response to LN.
Finally, LN-induced AChR aggregation does not involve the
phosphorylation of the muscle-specific tyrosine kinase receptor
(MuSK) or the AChR b subunit. We hypothesize that the inter-
action of LN with a-DG contributes to the growth and/or sta-
bilization of AChR microaggregates into macroaggregates at
the developing NMJ via a MuSK-independent mechanism.
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At the adult neuromuscular junction (NMJ), sites of transmitter
release are aligned precisely opposite postjunctional folds in the
muscle membrane. At the crests of the folds, acetylcholine recep-
tors (AChRs) are packed at a density of ;10,000/mm2 (Fertuck
and Salpeter, 1974), whereas in adjacent regions of the mem-
brane, the receptor density is ;1000-fold less. Before innervation,
AChRs are diffusely distributed, but within hours of the first
contact of the nerve terminal and muscle fiber, AChRs in the
postsynaptic membrane begin to aggregate (Bevan and Steinbach,
1977). These early synapses are composed of loose assemblies of
small receptor patches (Anderson and Cohen, 1977; Olek et al.,
1986) that subsequently coalesce into more tightly organized
receptor “plaques” that further increase in size and density until
they attain the proportions found in the adult postsynaptic mem-
brane (Steinbach, 1981).
Agrin released from the nerve terminal has been shown to
activate the muscle-specific tyrosine kinase receptor MuSK lead-
ing to the aggregation of AChRs in the postsynaptic membrane
(Valenzuela et al., 1995; DeChiara et al., 1996; Glass et al., 1996).
Several studies have shown that agrin, in addition to triggering
the aggregation of AChRs, also induces the aggregation of other
synaptic proteins including laminin (LN), the heparan sulfate
proteoglycan perlecan, acetylcholinesterase, muscle agrin,
rapsyn, a-actinin, filamin, vinculin, and a- and b-dystroglycan
(b-DG) (Daniels et al., 1984; Wallace, 1989; Nitkin and Roths-
child, 1990; Shadiack and Nitkin, 1991; Lieth et al., 1992; Cohen
et al., 1995). Furthermore, in skeletal muscle from MuSK knock-
out mice, there is a complete failure in synapse formation, indi-
cating that as for AChRs, agrin-induced aggregation of extracel-
lular matrix (ECM), membrane, and cytoskeletal proteins
requires the activation of MuSK. Therefore, agrin activation of
MuSK initiates the creation of a separate compartment within the
muscle fiber containing a specialized synaptic basal lamina (BL),
as well as membrane and cytoskeletal proteins.
Several previous results indicate that LN may assist agrin in the
formation and consolidation of postjunctional AChR aggregates.
For example, LN is concentrated at agrin-induced AChR aggre-
gates in culture, and isoforms of LN containing the b2 chain are
restricted to the NMJ (Hunter et al., 1989). Furthermore, LN has
been reported to induce AChR aggregation on cultured myotubes
and to enhance the aggregating activity of a neuroblastoma 3
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glioma hybrid cell-conditioned medium with agrin-like activity
(Vogel et al., 1983). Recently, Denzer et al. (1997) reported that
agrin isoforms containing a 15 amino acid N-terminal insertion
bind with different affinities to LN, showing a preference for
heterotrimers containing the synapse-specific b2 LN chain.
AChR aggregates induced by this agrin splice variant are consid-
erably smaller than are those induced by C-terminal fragments of
agrin, suggesting that the interaction of agrin with LN can mod-
ulate the size of AChR aggregates.
Several LN receptors have been shown to be expressed and
developmentally regulated in skeletal muscle and the C2 mouse
muscle cell line. These include members of the integrin family of
heterodimeric ECM receptors (Song et al., 1992; Collo et al.,
1993; Belkin et al., 1996) as well as the dual LN and agrin
receptor a-dystroglycan (a-DG), which is an extracellular periph-
eral membrane protein and a member of the dystrophin/utrophin-
associated protein complex (Smalheiser and Schwartz, 1987; Dou-
ville et al., 1988; Ervasti and Campbell, 1991, 1993; Ibraghimov-
Beskrovnaya et al., 1992; Matsumura et al., 1992; Gee et al.,
1993). Most integrins that bind LN contain the b1 subunit that is
found at NMJs (Bozyczko et al., 1989; Belkin et al., 1996) and at
agrin- and nerve-induced AChR aggregates in cultured myotubes
(Bozyczko et al., 1989; Anderson and Qiao Shi, 1996). LN also
binds with high affinity to a-DG, and this interaction is thought to
play a role in maintaining the structural integrity of the sarco-
lemma (Henry and Campbell, 1996). a-DG is concentrated at the
NMJ in vivo (Matsumura et al., 1992) and at AChR aggregates in
cultured myotubes (Cohen et al., 1995) and has been implicated
in AChR aggregation (Campanelli et al., 1994; Gee et al., 1994,
Cohen et al., 1995; but see Sugiyama et al., 1994). In the present
study, we sought to determine the role of LN in agrin-induced
AChR aggregation and to identify the receptor involved. We find
that agrin-induced aggregation of AChRs is accompanied by a
recruitment of LN at these aggregates and that exogenous LN
alone induces the aggregation of AChRs on C2 myotubes in
addition to potentiating the aggregating activity of agrin. We
further show that LN-mediated AChR aggregation does not
involve the phosphorylation of MuSK or the AChR b subunit.
Finally, we used three mutant cell lines derived from the C2 cell
line that express reduced levels of a-DG to demonstrate that this
receptor is responsible for the observed effects of LN on AChR
aggregation. Our results suggest a role for LN and a-DG in the
growth and/or stabilization of AChRs into compact aggregates
during synapse formation at the NMJ.
MATERIALS AND METHODS
Materials. LN was purified from Engelbreth–Holm–Schwarm (EHS)
tumor by the method of Timpl et al. (1982). Coomassie blue- and
silver-stained gels revealed only two bands at ;215 kDa (b/g chains) and
400 kDa (a chain) that did not cross-react with a monoclonal antibody to
the LN a2. Polyclonal anti-LN antiserum was produced by immunizing
rabbits with EHS tumor LN. This antiserum has been characterized
previously (Morissette and Carbonetto, 1995) and recognizes all three
subunits of LN 1 (a1, b1, and g1) with a very faint band at 150 kDa
corresponding to entactin. There is no cross-reactivity with agrin (F.
Montanaro and S. Carbonetto, unpublished observations) or LN a2
chain (Morissette and Carbonetto, 1995). Anti-LN antiserum was puri-
fied by chromatography on Affi-Gel Blue (Bio-Rad, Hercules, CA) ac-
cording to the manufacturer’s instructions and was subsequently dialyzed
into PBS, pH 7.2. Recombinant rat agrin(12,4,8) was purified from the
conditioned medium of COS cells expressing a truncated C-terminal
fragment (amino acids 1145–1940) (Ferns et al., 1993). Monoclonal
antibody (mAb) IIH6 ascites fluid was prepared as described previously
(Ervasti and Campbell, 1991). Monoclonal antibodies to b-DG and to the
core protein of mouse perlecan were purchased from Novo Castra
Laboratories (Newcastle upon Tyne, UK) and Chemicon (Temecula,
CA), respectively. Monoclonal antibody 3A3 is directed against the rat
integrin a1 subunit and was prepared as described previously (Turner et
al., 1989). The polyclonal antiserum to the integrin b1 subunit was
generated by immunizing rabbits with purified native rat integrin b1
subunit (Tawil et al., 1990). The polyclonal antiserum to mouse collagen
IV was purchased from Chemicon. Polyclonal anti-MuSK antiserum was
prepared by immunizing rabbits with a synthetic peptide corresponding
to the C-terminal 20 amino acids of the rat MuSK protein (Glass et al.,
1996).
Cell culture. C2 and S27 myotubes were cultured as described previ-
ously (Gee et al., 1994) on collagen-coated 18-mm-round glass coverslips
in scored wells on 100 mm Petri plates. For experiments involving the
DG-antisense cell lines, 11F, 11E, and control C2 cells were cultured on
Falcon tissue culture plastic dishes coated with 0.15% gelatin. Cells were
kept in growth medium (DMEM high glucose plus 10% fetal bovine
serum; plus 70 mg/ml G-418 for 11F and 11E cells only) until confluent.
Cultures were then switched to fusion medium (DMEM high glucose
plus 1% horse serum) and allowed to differentiate for an additional 4 d.
All cells were treated with LN, agrin, or anti-LN IgG on the third day of
fusion.
Immunofluorescence microscopy. To visualize surface AChRs, we incu-
bated myotubes with BODIPY- or rhodamine-conjugated a-bungarotoxin
(Molecular Probes, Eugene, OR) for 30 min at room temperature. Myo-
tubes were fixed with 2% paraformaldehyde in 0.1 M phosphate buffer, pH
7.2, for 20 min and rinsed three times with PBS. For antibody staining, the
myotubes were fixed as above and then blocked for 1 hr with PBS plus 1%
horse serum. Cells were incubated with primary antibody in blocking buffer
for 1 hr and then with the appropriate biotin-conjugated secondary anti-
body for an additional hour, followed by fluorescein-conjugated streptavi-
din for 20 min.
Quantification of AChR colocalization and number. All quantifications
were performed by visual inspection of a minimum of 10 random fields
using a 403 objective. For colocalization studies, AChR aggregates were
scored as partially overlapping with the antigen of interest if at least a
quarter of their surface colocalized with the antigen. AChR aggregates
were scored as completely overlapping if the antigen immunoreactivity
was coextensive with a-bungarotoxin staining in both size and shape.
Determination of the number of AChR aggregates per myotube segment
was performed as described previously (Gee et al., 1994). A myotube
segment corresponds to 5.6 3 10 3 mm 2.
Quantification of AChR number, size, and intensity for Table 2. Thirty-
five millimeter negatives were scanned into Adobe Photoshop for Win-
dows (version 2.5.1) using an Agfa Arcus II scanner and FotoLook
(version 2.05) with TWAIN acquisition. Brightness and contrast were
adjusted to 225 and 125, respectively. Files were saved in TIFF format
(for MacIntosh) and imported into NIH Image (version 1.59b). Images
were processed with Invert Filter; then the background was subtracted
using the two-dimensional rolling ball method (radius, 5–15).
Background-subtracted images were analyzed for particle size and mean
pixel intensity after thresholding the image. The mean pixel intensity is
the average gray value for all of the pixels in an aggregate. The possible
values for each pixel range from 0 (white) to 255 (black). Thresholded
images were carefully compared with their unprocessed counterparts to
ensure that AChR aggregate size and number were accurate. Measure-
ments were imported into Excel (version 5.0; Microsoft) and SigmaPlot
(version 5.0; Jandel Scientific, Corte Madera, CA) for analysis. AChR
aggregates of , 1.0 mm 2 were not included because image thresholding
of low intensity or out-of-focus aggregates accounted for the majority of
particles of this size.
Immunoprecipitation. For immunoprecipitations, cultures of 100 mm
dishes of C2 myotubes were treated with agrin or LN for 15 min, rinsed
with Ca 21- and Mg 21-free PBS containing 1 mM sodium vanadate, then
harvested by scraping, and pelleted. Cell pellets were extracted for 15
min on ice with 25 mM Tris-glycine, pH 7.5, 150 mM NaCl, 5 mM EDTA,
1% Triton X-100, 1 mM sodium vanadate, 50 mM sodium fluoride, 1 mM
aprotinin, 1 mM leupeptin, 1 mM pepstatin A, 1 mM benzamidine, 1 mM
iodoacetamide, and 1 mM PMSF. Insoluble material was pelleted by
centrifugation at 15,000 3 g for 10 min at 4°C. Extracts of C2 myotubes
were incubated with anti-MuSK antisera for 1 hr at 4°C with agitation;
then immune complexes were precipitated by addition of protein
G–Sepharose beads. The beads were pelleted at 1500 3 g and were
washed three times with 50 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 50 mM
sodium vanadate, and 1% Triton X-100. Bound proteins were eluted with
30 ml of reducing SDS-PAGE sample buffer. To isolate AChRs, we
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incubated C2 myotube cultures with 0.1 mg/ml biotin-conjugated
a-bungarotoxin for 1 hr at 25°C, harvested and extracted the cells as
described above, then added 100 ml of streptavidin–Sepharose beads,
and incubated the mixture at 4°C for 1 hr. The beads were washed and
prepared for SDS-PAGE as described above.
Western blot analysis. Samples were electrophoretically separated on
8% SDS-PAGE gels and transferred onto nitrocellulose membranes. The
proteins were probed with a monoclonal anti-phosphotyrosine antibody
(mAb 4G10) (Upstate Biotechnology, Saranac Lake, NY) in buffer
containing 5% BSA, 10 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 0.5%
Nonidet P-40, and 0.1% Tween 20. The blots were then incubated with
a horseradish peroxidase-conjugated anti-mouse Ig secondary antibody
(Amersham, Arlington Heights, IL). Bound antibody was visualized by
chemiluminescence (ECL) (Amersham).
RESULTS
LN colocalizes with AChR aggregates in C2 cells
Previous studies have shown that LN colocalizes with AChR
aggregates in cultured myotubes (Vogel et al., 1983; Bayne et al.,
1984; Olwin and Hall, 1985; Nitkin and Rothschild, 1990; Gordon
et al., 1993) and that it is concentrated at synapses in vivo (Sanes
et al., 1990). In addition, agrin treatment of cultured chick myo-
tubes was also shown to promote a rearrangement of LN on the
cell surface (Nitkin and Rothschild, 1990). We therefore sought
to confirm and quantify the presence of LN at both spontaneous
and agrin-induced AChR aggregates in C2 myotubes. Cultures
were double labeled with a polyclonal antiserum to LN and with
rhodamine-conjugated a-bungarotoxin to visualize AChRs. LN
was found to be concentrated at most spontaneous and agrin-
induced AChR aggregates (Table 1, Fig. 1). In agreement with a
previous report (Gordon et al., 1993), LN immunoreactivity was
also found in a punctate pattern on the myotube surface and in a
few patches devoid of AChRs (Fig. 1). The amount of overlap of
LN with AChR aggregates was categorized as partial or com-
plete. Overlap was considered partial when $25% of the surface
of the AChR aggregate was associated with LN immunoreactivity
and complete when the two proteins were coextensive. In un-
treated C2 myotubes, ;81% of spontaneous AChR aggregates
overlapped partially with LN, and in 38%, the overlap was com-
plete (Table 1). Overnight treatment of C2 myotubes with 200 pM
of a recombinant neural agrin fragment [C-Agrin(4,8) , hereafter
referred to as agrin] increased the overlap of LN in almost all
AChR aggregates, with a more than twofold increase in the
number of AChR aggregates that overlap completely with LN
(Table 1). To determine the specificity of this recruitment of LN
to AChR aggregates in C2 cells, we mapped the distribution of
other proteins found concentrated at the neuromuscular junction
in vivo (Sanes et al., 1990; Belkin et al., 1996) and at spontaneous
and agrin-induced AChR aggregates: collagen IV, the heparan
sulfate proteoglycan perlecan, and the integrin b1 subunit. We
found that only perlecan shows a high degree of overlap with
spontaneous AChR aggregates, and this overlap is increased by
agrin treatment. In contrast, collagen IV showed a poor colocal-
ization with spontaneous AChR aggregates and was often con-
centrated in large patches devoid of AChRs on the cell surface
(Fig. 1, Table 1). Similar poor colocalization was found with
antisera for fibronectin (Montanaro and Carbonetto, unpub-
lished observations). Agrin did not greatly increase localization
of collagen IV at AChR aggregates, nor did it seem to alter its
distribution on the cell surface. Only a subset of collagen IV
chains have been shown to be specifically concentrated at syn-
apses (Sanes et al., 1990), and we cannot exclude the possibility
that the low level of colocalization of collagen IV with AChR
aggregates is attributable to the inability of our antibody to
recognize the synapse-specific collagen IV chains. However, our
data indicate that agrin does not cause a reorganization of all BL
components but selectively recruits LN and perlecan to AChR
aggregates in C2 myotubes. Similar results have been reported
with cultures of primary myotubes (Nitkin and Rothschild, 1990).
Two classes of LN receptors are expressed in skeletal muscle
and C2 cells, integrins and a-DG (Collo et al., 1993; Ervasti and
Campbell, 1993; Song et al., 1992; Gee et al., 1994; Belkin et al.,
1996). Integrins comprise a family of cell adhesion molecules
composed of heterodimers of a and b subunits (for review, see
Hynes, 1992). LN-binding integrins found in skeletal muscle
contain the b1 subunit, and their expression is developmentally
regulated in both muscle and C2 cells (Collo et al., 1993; Belkin
et al., 1996). Antibodies to the b1 subunit label NMJs (Belkin et
al., 1996) as well as AChR aggregates in Xenopus myocyte and
chick myotube cultures (Bozyczko et al., 1987; Anderson et al.,
1996). In our studies, we used an antiserum directed against the
extracellular domain of the integrin b1 subunit that should rec-
ognize all cytoplasmic splice variants expressed in these cells. We
found a very poor correlation with both spontaneous and agrin-
induced AChR aggregates in C2 cells (Fig. 1, Table 1). Agrin did
not seem to change the distribution of this integrin subunit that
remained concentrated in large plaques on the cell surface (Fig.
1, open arrow), its distribution resembling more that of collagen
IV than that of LN. By contrast, both a- (data not shown) and
b-DG (Fig. 1) are concentrated at and overlap completely with
essentially all AChR aggregates (.95%). Taken together, our
results show that agrin specifically recruits LN and perlecan at
AChR aggregates in C2 cells. Furthermore, the low level of
Table 1. Overlap of LN and other proteins with AChR aggregates
AChR Aggregates
Spontaneous Agrin-induced
100% Overlap 25–100% Overlap 100% Overlap 25–100% Overlap
LN 38% (n 5 489) 81% (n 5 139) 83% (n 5 129) 95% (n 5 129)
Perlecan 46% (n 5 91) 66% (n 5 91) 95% (n 5 156) 99% (n 5 156)
Collagen IV N.D. 56% (n 5 247) N.D. 68% (n 5 285)
Integrin b1 subunit 0% (n 5 117) 23% (n 5 117) 2% (n 5 115) 12% (n 5 115)
Untreated C2 myotubes (spontaneous) and C2 myotubes that had been treated overnight with 200 pM agrin (agrin-induced)
were double labeled for AChR aggregates using rhodamine-conjugated a-bungarotoxin and for the proteins indicated using
indirect immunofluorescence with specific antibodies. The extent of overlap of these proteins with AChR aggregates was
quantified by visual inspection. Overlap was considered complete if 100% of an aggregate was coextensive with immuno-
reactivity for the protein and partial if ,100% but .25% was coextensive. Aggregates with ,25% overlap with the protein
were considered nonoverlapping. Data indicate the percentage of AChR aggregates that scored positive for overlap. The
total number of AChR aggregates visualized is given in parenthesis. N.D., Not determined.
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colocalization of the integrin b1 subunit with AChR aggregates
in C2 cells suggests that this receptor is unlikely to be responsible
for the recruitment of LN into aggregates. Rather, a-DG, which
is consistently concentrated at both spontaneous and agrin-
induced AChR aggregates, seems a better candidate.
LN induces large AChR aggregates
The possibility that LN is involved in later stages of AChR
aggregate formation, such as the maturation of aggregates, was
suggested by the observation that agrin-induced reorganization
of the ECM lags behind AChR aggregation (Nitkin and Roths-
child, 1990). To test this possibility, we treated C2 myotubes with
either agrin or LN, measured the number, size, and density of
AChR aggregates, and compared these values with those of
control cultures. In the absence of added agrin or LN, C2 myo-
tubes had an average of 9 6 1 spontaneous aggregates per field
with a mean size of 16.4 6 1.8 mm2 (n 5 10 fields; Table 2, Fig.
2A,E). Spontaneous aggregates had a mean pixel intensity of
133 6 6 (out of a possible 255), reflecting the density of AChRs
within an aggregate. Treatment of C2 myotubes with 200 pM agrin
induced a more than threefold increase in the number of AChR
aggregates compared with control cultures (Table 2, Fig. 2B,F);
however this increase in number was accompanied by a twofold
decrease in size and a 1.4-fold decrease in apparent density. In
Figure 1. Colocalization of some synaptic proteins with
agrin-induced AChR aggregates. C2 myotubes were in-
cubated with 100 pM agrin for 18 hr and then double
labeled with rhodamine-conjugated a-bungarotoxin and
with antibodies specific for LN, perlecan (HSPG), colla-
gen IV (CN IV ), integrin b1 subunit (b1), or b-DG. Both
LN and perlecan are distributed diffusely on the surface
of the myotubes and in the surrounding matrix but are
highly concentrated at and fully coextensive with most
AChR aggregates (long arrows). Collagen IV and the
integrin b1 subunit were present in diffuse patches de-
void of AChRs (open arrows) and were found to colocal-
ize with only a few AChR aggregates (long arrows). The
vast majority of AChR aggregates had no detectable
collagen IV or integrin b1 immunoreactivity associated
with them (short arrows). b-DG immunoreactivity was
present over the entire myotube and highly concentrated
at both large and small AChR aggregates (long arrows).
Scale bar, 20 mm.
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spite of the small size of the AChR aggregates, their large
number resulted in an increase from 150 to 306 mm2 in the total
area per field occupied by AChR aggregates (Table 2).
Treatment of C2 cells with 60 nM LN resulted in an approxi-
mately twofold increase in the number of AChR aggregates
compared with control cultures (Table 2, Fig. 2C,G). The average
size of LN-induced AChR aggregates was more than double that
of agrin-induced aggregates, resulting in a greater total area
occupied by AChR aggregates (Table 2). Furthermore, the AChR
density of LN-induced aggregates was higher than that of either
spontaneous or agrin-induced aggregates. Thus LN alone in-
duces the formation of large, dense AChR aggregates. To explore
the function of LN in agrin-induced AChR aggregation, we
incubated C2 myotubes with 200 pM agrin in the presence of 100
mg/ml anti-LN antiserum. This antiserum was raised against
purified EHS LN and does not cross-react with the recombinant
agrin used in these experiments. As a control for nonspecific
antibody effects, an equal concentration of a polyclonal antibody
to collagen IV was added to identical cultures of C2 myotubes,
and no obvious effect on the size or number of AChR aggregates
was observed (data not shown). Only in cultures treated with the
anti-LN antiserum was there a dramatic increase in the number of
AChR aggregates (Table 2, Fig. 2D,H). These AChR aggregates
were half the size of the aggregates observed in cultures treated
with agrin alone and had a slightly lower AChR density. A large
proportion (.80%) of the myotubes cultured in the presence of
anti-LN antiserum showed only microaggregates on their surface
(see Fig. 2D,H). These microaggregate-rich myotubes were
sometimes seen in control and agrin-treated cultures. However
they were absent in cultures treated with LN alone or with LN
and agrin together. Because the total area covered by AChR
aggregates in the presence of the anti-LN antiserum is compara-
ble with that for agrin alone, this antiserum did not seem to
completely disperse aggregates into individual AChRs. From
these results, we hypothesize that agrin increases the number of
AChR microaggregates, while recruiting LN to promote the
formation of large, high density aggregates from microaggregates
or possibly to inhibit the breakup of larger aggregates into
microaggregates.
LN-induced AChR aggregation is mediated by a-DG
Our immunocytochemical data on integrin and a-DG localiza-
tion favored the latter as a receptor mediating the effects of LN
on AChR aggregation. To test this further, we quantified the
induction of AChR aggregates by LN on C2 myotubes and on a
genetic variant of the C2 muscle cell line S27, which is deficient in
the synthesis of glycosaminoglycans (Gordon and Hall, 1989). We
and others (Gee et al., 1994; Sugiyama et al., 1994) have shown
previously that S27 cells have reduced expression of a-DG as well
as reduced binding of the residual a-DG to agrin and LN. These
cells also have no spontaneous AChR aggregates and respond
poorly to agrin (Gordon et al., 1993). In C2 cells incubated for 18
hr with various concentrations of LN, there was a maximal
increase (twofold) in AChR aggregates at 60 nM LN (Fig. 3). In
contrast, LN failed to cause aggregation of AChRs on S27 myo-
tubes, even at concentrations as high as 120 nM. Like spontaneous
and agrin-induced aggregation, LN-induced aggregation seems
to require a functional a-DG and the normal synthesis of
glycosaminoglycans.
Because a-DG is not the only protein affected by the muta-
tion in S27 cells, we assessed the involvement of a-DG in
LN-induced AChR aggregation with mAb IIH6. mAb IIH6
recognizes a unique carbohydrate epitope on a-DG and inhib-
its binding of both LN and agrin to a-DG on blots (Gee et al.,
1994; Sugiyama et al., 1994). A control monoclonal antibody to
the rat integrin a1 subunit, mAb 3A3, had no effect on LN-
induced aggregation (data not shown). Treatment of C2 cells
with LN in the presence of increasing concentrations of mAb
IIH6 resulted in a dose-dependent inhibition of LN-induced
AChR aggregation (Fig. 4). A significant effect was observed at
mAb IIH6 concentrations as low as 1:200 dilution. Higher
concentrations of mAb IIH6 decreased the number of AChR
aggregates to that occurring spontaneously in C2 cells. No
obvious change in the morphology of the remaining aggregates
was observed. Although others (Campanelli et al., 1994; Co-
hen et al., 1995; but see Sugiyama et al., 1994) have reported
effects of mAb IIH6 similar to those we saw with the anti-LN
antiserum, in our hands these antibodies had different effects
possibly because the functions of a-DG in AChR aggregation
are not limited to those of LN.
To confirm that a-DG is involved in LN-induced AChR
aggregation, we generated C2 clonal cell lines that stably
express antisense cDNA to DG. Two such cell lines, 11F and
11E, show reductions of 50 and 80%, respectively, in a-DG
expression relative to C2 cells. These cells fuse to form myo-
tubes and express normal levels of other proteins including
adhalin, LN, and AChRs (M. Lindenbaum, F. Montanaro, and
S. Carbonetto, unpublished observations). C2, 11F, and 11E
myotubes were incubated in the presence of 60 nM LN for 18
hr and then assayed for AChR aggregation. Figure 5 shows that
LN induced a 1.8 –2-fold increase in the number of AChR
aggregates in C2 cells regardless of the level of spontaneous
AChR aggregates. In contrast, there was little change in the
number of AChR aggregates in 11F and 11E cells treated with
LN (Fig. 5). In other experiments (see below; C. Jacobson, F.
Montanaro, M. Lindenbaum, S. Carbonetto, and M. Ferns,
unpublished observations), we have shown that 11F and 11E
cells produce a significant, although reduced, response to agrin
when compared with C2 cells, indicating that they are not
inherently incapable of responding to agents known to induce
AChR aggregation. Taken together, our results suggest that
a-DG is required for LN-induced AChR aggregation in C2
cells.














Control 9 6 1 (n 5 11) 16.4 6 1.8 133 6 6 150
Agrin (200 pM) 34 6 4 (n 5 13) 7.5 6 0.9 95 6 9 306




101 6 14 (n 5 10) 3.8 6 0.2 73 6 6 385
Cultures were treated overnight with the indicated concentrations of neural agrin
(Ferns et al., 1993), LN, and/or purified anti-laminin IgG. AChR aggregate number,
size, and intensity were quantitated as described in Materials and Methods. The
means for the indicated number of fields (n) containing at least one AChR aggregate
are shown 6 SEM. Total area refers to the area of the myotube occupied by AChR
aggregates and is the product of the mean number of aggregates per field and the
mean area of each aggregate.
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LN interaction with a-DG enhances agrin-induced
AChR aggregation
Vogel et al. (1983) reported that LN can enhance the AChR
aggregating activity of a factor in neuroblastoma-conditioned
medium. Because agrin is produced by a variety of neural cells,
we tested whether recombinant agrin might also act cooperatively
with LN in this regard and further whether this was mediated by
a-DG. To optimize the sensitivity of this assay, we used a sub-
threshold concentration of LN (12 nM) that alone did not cause
any increase in the number of AChR aggregates in C2, 11F, or
11E cells (Fig. 6). Addition of agrin alone to C2, IIF, and IIE
cultures caused a significant increase in the number of AChR
aggregates. This increase was enhanced significantly by simulta-
neous treatment with agrin and LN (12 nM) in C2 and to a lesser
extent in IIF cells, but there was no effect in IIE cells. These
results show that LN can potentiate the activity of agrin and that
a-DG is involved in this process.
LN does not induce the phosphorylation of MuSK or
the AChR b subunit
Neural agrin induces a rapid, but transient, phosphorylation of
the receptor tyrosine kinase MuSK that subsequently leads to the
phosphorylation of the AChR b subunit (Wallace et al., 1991; Qu
and Huganir, 1994; DeChiara et al., 1996; Ferns et al., 1996; Glass
et al., 1996). We therefore sought to determine whether LN-
induced AChR aggregation is similarly dependent on the phos-
phorylation of MuSK and leads to the phosphorylation of the
AChR b subunit. AChRs were isolated using a-bungarotoxin
conjugated to Sepharose beads, and MuSK was immunoprecipi-
tated. Isolates were then analyzed by SDS-PAGE and immuno-
Figure 3. LN induces AChR aggregation in C2 but not S27 cells. Cul-
tures were treated for 18 hr with 0, 12, 24, 60, or 120 nM LN, labeled with
rhodamine-conjugated a-bungarotoxin, and the number of AChR aggre-
gates per myotube segment was quantified. Data points represent the
mean 6 SEM of four experiments. For each experiment, 10 fields taken
at random from each of four coverslips were quantified. LN induces the
first significant increase in the number of AChR aggregates in C2 cells
(open circles) at a concentration of 24 nM. The response saturates at 60 nM
with a twofold increase in the number of AChR aggregates over control.
An asterisk indicates numbers of LN-induced AChR clusters that are
statistically significant from control as assessed by ANOVA and Fisher’s
test ( p , 0.05). In contrast, no AChR aggregates were present in S27
cultures ( filled circles) at any concentration of LN tested.
Figure 2. LN affects the size of AChR
aggregates. Cultures of C2 myotubes
were incubated overnight in fusion me-
dium alone (A, E) or in fusion medium
containing 200 pM agrin (B, F ), 60 nM
LN (C, G), or 200 pM agrin plus
100 mg /ml anti-LN IgG (D, H ). A–D,
Representative fields of C2 myotubes
labeled with rhodamine-conjugated
a-bungarotoxin for each treatment.
E–H, Representative frequency distri-
bution histograms of AChR aggregate
areas. Note that the scale of the y-axis
of H (agrin 1 anti-LN) is four times
that of E–G. The addition of LN to C2
myotube cultures results in an increase
in the area of AChR aggregates,
whereas the addition of anti-LN IgG
results in an dramatic increase in the
number of small AChR aggregates (,5
mm 2). Scale bar, 10 mm.
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blotting with a monoclonal anti-phosphotyrosine antibody
(4G10). Blots were then stripped and reprobed with mAb 124 to
the AChR b subunit or with anti-MuSK antiserum to verify the
identity of the phosphorylated bands (data not shown). Treat-
ment of C2 myotubes with 200 pM neural agrin leads to a rapid
phosphorylation of MuSK (;110 kDa; Fig. 7A). However, treat-
ment with LN did not induce MuSK phosphorylation, even at
concentrations that induce maximal aggregation (Fig. 3B). Agrin
also induced a robust increase in tyrosine phosphorylation of an
;50 kDa band that corresponds in size to the AChR b subunit
(Fig. 7B). In contrast, concentrations of LN that are sufficient to
induce maximal aggregation do not phosphorylate the AChR b
subunit above endogenous levels seen in untreated cultures (Fig.
7B). We conclude that the observed effects of LN on the size and
number of AChR aggregates do not involve phosphorylation of
either MuSK or the AChR b subunit.
DISCUSSION
The formation of the postsynaptic apparatus of the skeletal neu-
romuscular junction is a complex process involving ECM, mem-
brane, and cytoskeletal elements (for review, see Hall and Sanes,
1993; Carbonetto and Lindenbaum, 1995). Agrin released from
nerve terminals activates MuSK to trigger events within muscle
that lead to the aggregation of AChRs in the postsynaptic mem-
brane. Diffusely distributed AChRs on the muscle cell surface
first form loose assemblies of microaggregates beneath the nerve
terminal that later coalesce into large aggregates (Anderson and
Cohen, 1977; Steinbach, 1981). The results presented here sug-
gest that LN is important in the later stages of this process and
that it acts through a-DG via a MuSK-independent mechanism.
Our results extend previous data (Vogel et al., 1983) on LN
stimulation of AChR aggregation by demonstrating a role for LN
in determining the size and density of AChR aggregates. LN-rich
regions are coextensive with a majority, but not all, of spontane-
ous and agrin-induced AChR aggregates. In untreated C2 myo-
tubes, 81% of spontaneous aggregates are closely associated with
LN. This value agrees well with results obtained in an earlier
study in which 70–90% of spontaneous receptor aggregates in
chick myotube cultures colocalized with LN (Bayne et al., 1984).
Agrin causes a dramatic change in the distribution of LN on the
cell surface, reflected by the twofold increase in AChR aggre-
gates that overlap completely with LN. In addition, we show that
treatment of cultures with agrin and an anti-LN antiserum leads
to the formation of AChR microaggregates with an apparent
lower AChR density, consistent with the notion that endogenous
LN is necessary for their cohesion. These observations could
suggest that the recruitment of LN at the nascent neuromuscular
synapse by agrin might assist the latter in forming a continuous
densely packed AChR aggregate under the nerve terminal. In-
deed, microaggregates formed in the presence of the anti-LN
antiserum resemble those seen in the early stages of AChR
aggregation at neuromuscular synapses forming in vivo (Stein-
bach, 1981) and at synapses between neurites and myotubes in
vitro (Anderson and Cohen, 1977; Kidokoro et al., 1980; Role et
al., 1985). Microaggregates are also observed at initial stages of
AChR aggregation induced by bath-applied agrin, where AChR
microaggregates (,4 mm2) begin forming within 1–2 hr of adding
Figure 4. mAb IIH6 against a-DG inhibits LN-induced AChR aggrega-
tion. Cultures of C2 myotubes were incubated for 18 hr in medium alone
(control ) or in medium containing 48 nM LN and increasing concentra-
tions of mAb IIH6 against a-DG. For each condition, the number of
AChR aggregates per myotube segment was determined for three exper-
iments. For each experiment, 10 fields taken at random from each of three
to four coverslips were quantified. At this concentration, LN induced an
;30% increase in the number of AChR aggregates per myotube segment
compared with control ( filled diamond, p , 0.01). mAb IIH6 significantly
decreased the number of AChR aggregates compared with LN treatment
in a dose-dependent manner at dilutions as high as 1:200 (*, p , 0.01; **,
p , 0.001). Although treatment with high concentrations of mAb IIH6
decreased the number of AChR aggregates below spontaneous levels,
this decrease was not statistically significant. Values represent
means 6 SEM, and significant differences from control ( filled dia-
mond) or from LN-treated (*) cultures were determined by ANOVA
followed by Fisher’s test.
Figure 5. DG-antisense clones fail to aggregate AChRs in response to
LN. 11F and 11E cells show reductions in a-DG expression of 50 and
80%, respectively, compared with parental C2 cells. Cells were treated for
18 hr with 60 nM LN and labeled with rhodamine-conjugated
a-bungarotoxin, and the number of AChR aggregates per myotube seg-
ment was quantified. LN (hatched bars) induced a twofold increase in
AChR aggregates in C2 cells compared with control nontreated cultures
( filled bars). However, both 11F and 11E cells were unresponsive to LN,
indicating that a-DG is necessary for LN-induced AChR aggregation.
Values represent means 6 SD of two coverslips from one representative
experiment; 15–20 fields for each of the two coverslips per treatment and
per cell type were quantified. Data from two separate experiments were
not pooled because of variability in the level of spontaneous AChR
aggregates in C2 cells. An asterisk indicates a statistically significant
difference between control and LN treatment within each cell type ( p ,
0.05, t test).
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agrin to chick myotubes in culture (Godfrey et al., 1984; Wallace,
1988). Larger aggregates (.4 mm2) are seen at later times (12–20
hr) and are formed in part by lateral migration and fusion of
pre-existing microaggregates (Wallace, 1988). During this time,
the total area occupied by AChR aggregates and their density
increase. Similarly, we find that AChR aggregates induced by LN
exhibit an increased size and density compared with their agrin-
induced counterparts. These observations support a model in
which LN promotes the fusion of microaggregates into larger,
more densely packed aggregates. However, they do not eliminate
the possibility that LN stabilizes large aggregates once they have
formed and that the anti-LN antiserum leads to the dispersal of
these preformed macroaggregates.
In C2 cells, LN induces AChR aggregation in a dose-
dependent manner with a maximal effect at 60 nM. In our hands,
LN first shows a significant effect on AChR aggregation at 24 nM;
however Vogel et al. (1983) reported an effect with only 1.2 nM
LN. One possible explanation for this difference could be the
presence of small amounts of agrin in the LN preparation used by
Vogel et al. (1983). Coomassie blue and silver staining of our
purified LN revealed only a broad band at ;200 kDa and a
second band at ;400 kDa corresponding to the b/g and a chains
of LN, respectively (Montanaro and Carbonetto, unpublished
observations). We further tested the purity of our LN by immu-
noblot with antibodies to agrin and LN a2 chain (merosin) and
found that neither of these proteins was present (Montanaro and
Carbonetto, unpublished observations). Alternatively, this ob-
served difference may derive from the different types of cells used
and from a relative weak response of C2 cells to exogenous LN
compared with primary myotube cultures and G8-1 cells.
Agrin-induced AChR aggregation has been shown to require
activation of the tyrosine kinase receptor MuSK and to lead to
the phosphorylation of the AChR b subunit. Subsequent identi-
fication, cloning, and functional studies of MuSK (Valenzuela et
al., 1995; DeChiara et al., 1996; Glass et al., 1996) indicated that
its activation is responsible for initiating virtually all events in
presynaptic and postsynaptic differentiation (DeChiara et al.,
1996). Our studies indicate that LN-induced AChR aggregation
does not involve the phosphorylation of either MuSK or the
AChR b subunit, even at concentrations that induce maximal
receptor aggregation. We would therefore predict that phosphor-
ylation inhibitors or a lack of MuSK would have no effect on this
process in vitro. The complete lack of AChR aggregates in MuSK
null mice indicates that in vivo LN and agrin do not induce the
aggregation of AChRs via parallel pathways. Instead we envisage
a model in which LN acts downstream of agrin-induced MuSK
activation to potentiate the action of agrin and to consolidate
AChR microaggregates into larger aggregates or to stabilize
Figure 6. LN potentiates the AChR aggregating activity of agrin via its
interaction with a-DG. Cells were treated with 12 nM LN (wide hatched
bars), 100 pM agrin ( fine hatched bars), or both ( filled bars) for 18 hr, and
the number of AChR aggregates per myotube segment was quantified as
described in Materials and Methods. The concentration of LN used is
subthreshold and does not affect the number of AChR aggregates com-
pared with control cultures (open bars) for all cell types. LN enhances the
effect of agrin by twofold and 1.7-fold in C2 and 11F cells, respectively.
However, in 11E cells, where the a-DG level is only 20% of that in C2
cells, LN does not significantly enhance the effect of agrin. Note that in
both DG-antisense clones agrin alone induces AChR aggregation. Values
represent means 6 SD for two experiments. For each experiment, 15–20
fields from each of two coverslips were quantified. An asterisk indicates a
statistically significant difference between agrin and agrin 1 LN treat-
ment within each cell type ( p , 0.05, t test).
Figure 7. LN does not induce the phosphorylation of MuSK and the
AChR b subunit. C2 myotubes were treated for 15 min with the indicated
concentrations of neural agrin or LN; then AChRs or MuSK were
purified from the cell extracts (see Materials and Methods). The isolates
were analyzed by SDS-PAGE, transferred to nitrocellulose, and then
assayed for phosphotyrosine content by immunoblotting with mAb 4G10.
A, Anti-phosphotyrosine immunoblot of MuSK immunoprecipitates.
Treatment of C2 myotubes with 200 pM agrin produced a large increase in
MuSK phosphorylation compared with endogenous levels. LN, on the
other hand, failed to induce MuSK phosphorylation at either of the two
concentrations tested. B, Anti-phosphotyrosine immunoblot of purified
AChR subunits. A prominent band at ;50 kDa, corresponding in size to
the AChR b subunit, is evident in AChR isolates from cells treated with
100 pM agrin. In contrast, treatment of C2 myotubes with either 60 or 120
nM LN did not induce the phosphorylation of the AChR b subunit above
the level seen in untreated cells. Molecular mass standards are indicated
at the right of each panel (in kDa).
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microaggregates within the forming subsynaptic receptor
“plaque.”
While this paper was being reviewed, Sugiyama et al. (1997)
published a paper showing that LN 1, but not LN 2 or LN 11,
induces AChR clustering in a muscle cell line derived from
MuSK knock-out mice, although at a 20-fold lower level than that
in C2 cells (DeChiara et al., 1996). In addition, they demonstrated
that LN-induced AChR aggregation occurs at a much slower rate
than does agrin-induced AChR aggregation. Like us, they con-
cluded that LN induces the aggregation of AChRs via a pathway
that does not involve MuSK signaling but that in vivo activation of
MuSK is required to initiate AChR aggregation. Furthermore,
they find that the aggregating activity of LN is determined by the
identity of its a chain. Our results complement and extend those
of Sugiyama et al. (1997) by implicating a-DG as the receptor that
mediates this MuSK-independent aggregation. a-DG is known to
bind specifically to G domains in the LN a chain (Gee et al.,
1993) but is known to bind with similar affinity to LN 1 and LN
2 (Yamada et al., 1994, 1996). The unique ability of LN 1 to
induce AChR aggregation could result from modulation of LN
binding to a-DG by heparan sulfate proteoglycans. Indeed hep-
arin has been shown to modulate differentially the interaction of
LN 1 and LN 2 to a-DG (Pall et al., 1996). Alternatively, the LN
a2 chain is much more prone to proteolysis than is the a1 chain
during purification (Leivo and Engvall, 1988; Ehrig et al., 1990),
and this can result in loss of the G domains and a loss of binding
to a-DG. This could explain the reported inability of purified LN
2 to induce AChR aggregation and would further support our
observations that a-DG mediates this aggregation.
Our data indicate that the effects of agrin and LN on C2 cells
may not be mediated by integrins but rather involve the dual agrin
and LN receptor a-DG. First, a-DG is immunocytochemically
localized at AChR aggregates where LN appears concentrated,
and it is the only protein detected in overlays of C2 myotube
extracts probed with LN (Gee et al., 1994). Second, the Kd for LN
binding to a-DG (;90 nM; Gee et al., 1993) is close to the
concentration of LN that induces half-maximal aggregation on
C2 myotubes (;30 nM). Third, S27 cells do not aggregate AChRs
in response to LN. Although these cells synthesize normal
amounts of LN and deposit it into the ECM, they do not retain
LN on their surfaces (Gordon et al., 1993). Consistent with this
observation, the binding of LN to a-DG is dramatically decreased
in S27 myotube extracts compared with C2 extracts (Campanelli
et al., 1994; Gee et al., 1994; Sugiyama et al., 1994). Moreover,
the amount of full-size a-DG is greatly reduced in S27 cells
(Sugiyama et al., 1994). Thus, a reduction in a-DG levels or in its
affinity for LN may be responsible for the inability of S27 cells to
retain LN on their surfaces and to aggregate AChRs in response
to exogenous LN. Fourth, mAb IIH6 against a-DG blocks LN-
induced receptor aggregation in a dose-dependent manner. This
antibody inhibits the binding of both LN and agrin to a-DG and
has been reported previously to interfere with agrin-induced
AChR aggregation (Campanelli et al., 1994; Gee et al., 1994;
Cohen et al., 1995; but see Sugiyama et al., 1994). Interestingly, in
our hands, mAb IIH6 and the anti-LN antiserum had different
effects on AChR aggregation, the former affecting the number of
aggregates and the latter their size and number. This difference
could be attributable to the fact that in C2 myotubes mAb IIH6
interferes with a-DG binding to LN and muscle agrin, which
could also be involved in AChR aggregation. Finally, we have
found that two C2-derived cell lines transfected with antisense
DG cDNA and expressing reduced levels of a-DG do not show
significant AChR aggregation in response to LN. 11F and 11E
cells show a specific decrease in a-DG expression with levels 50
and 20% of parental C2 cells, respectively. Like S27 cells, both
11F and 11E cells show an abnormal LN deposition on their
surface (Lindenbaum, Montanaro, and Carbonetto, unpublished
observations) and a decreased response to agrin (Jacobson, Mon-
tanaro, Lindenbaum, Carbonetto, and Ferns, unpublished obser-
vations). Taken together, these data suggest a role of a-DG in
LN-induced AChR aggregation. In addition, we have shown that
a subthreshold concentration of LN can significantly potentiate
the AChR aggregating activity of recombinant neural agrin,
providing further evidence of a cooperation between LN and
agrin in AChR aggregation. As for LN-induced AChR aggrega-
tion, this synergistic effect of LN on agrin also seems to be
mediated by a-DG because it was not observed in 11E cells that
have the lowest level of a-DG expression.
Experiments of others have emphasized the presence of inte-
grins at the NMJ in vivo and at AChR aggregates in culture
(Bozyczko et al., 1987; Anderson et al., 1996; Belkin et al., 1996).
Although we are unaware of any perturbation experiments
with the function-blocking antibodies used for localization
(Bozyczko et al., 1987) this precise colocalization suggests that
integrins are involved in aggregation and makes them a potential
candidate for mediating the effects of LN on muscle cells. Some-
what surprisingly however, we have found a poor localization of
integrins in agrin-induced AChR aggregates on C2 myotubes.
The antibody used in these experiments is directed against the b1
subunit that is common to most, if not all, integrin LN receptors.
This antiserum recognizes the extracellular domain of the b1
subunit and should therefore cross-react with the two cytoplasmic
splice variants b1A and b1D recently identified in skeletal muscle
and C2 cells. In particular, b1D was localized to the NMJ, where
it is believed to act as a LN receptor by dimerizing with the a7
subunit. We have no definite explanation for the low colocaliza-
tion of integrins with agrin-induced AChR aggregates in C2 cells.
However, in all previous studies, AChR aggregation in culture
was induced by either cocultured neurons or extracts containing
full-length agrin. It is therefore possible that recruitment of
integrins to AChR aggregates requires additional nerve-derived
factors not present in our culture system or agrin domains not
present in our recombinant agrin fragment. Further experiments
with full-length agrin and function-blocking anti-integrin anti-
bodies are required to address this issue.
How does LN stimulate the formation of large densely packed
AChR aggregates? Previous studies have shown that LN can
self-polymerize in solution via domains at the end of each of its
short arms (Yurchenco et al., 1990; Colognato-Pyke et al., 1995)
and forms an independent network in basement membranes
(Yurchenco et al., 1992). Thus, one possibility is that LN self-
associates into a multimeric structure and in so doing “traps”
AChR microaggregates at sites of assembly. A similar mechanism
has been proposed by Cohen et al. (1997) to mediate the aggre-
gation of a-DG, b-DG, and dystrophin by exogenous LN in
Xenopus myocytes. Interestingly, this aggregation is not blocked
by inhibitors of tyrosine phosphorylation. Similarly, exogenous
LN causes the aggregation of a-DG on C2 myotubes (Linden-
baum, Montanaro, and Carbonetto, unpublished observations).
Although there is no evidence of a direct interaction of LN with
the AChR, expression of a- and b-DG together with rapsyn in
nonmuscle cells results in a coclustering of these proteins (Apel et
al., 1995). b-DG could therefore interact with rapsyn that is able
to aggregate AChRs when expressed in nonmuscle cells (Froeh-
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ner et al., 1990; Phillips et al., 1991; Maimone and Merlie, 1993;
Scotland et al., 1993). Hence, the aggregation of a/b-DG com-
plexes by LN in muscle cells may cause aggregation of AChRs via
rapsyn by a MuSK-independent mechanism.
During synapse formation, the binding of agrin to MuSK would
activate rapsyn and initiate aggregation of AChRs, MuSK, and
a-DG as well as LN bound to a-DG. The local increase in the
concentration of LN may potentiate direct interactions between
LN–LN as well as LN–agrin (Denzer et al., 1997) molecules and
lead to the coalescence of microaggregates of AChRs into large
dense aggregates similar to those found at mature synapses.
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